Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-11-13
1993-08-24
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3702, C07K 506
Patent
active
052389243
ABSTRACT:
There is disclosed the use of angiotensin converting enzyme (ACE) inhibitors to alter the progression of renal diseases by affecting intraglomerular hemodynamics and proteinuria; i.e., affecting blood pressure within the functioning, filtering tissue of the kidney and the quantity of albumin in the urine.
REFERENCES:
S. Rasmussen et al., Scand J. Urol Nephrol, 17, 209-212 (1983).
Brigham & Women's Hospital
DiPrima Joseph F.
Lee Lester L.
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Treatment of renal diseases with ace inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of renal diseases with ace inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of renal diseases with ace inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-829299